NovoCure Limited Ordinary Shares (NASDAQ: NVCR) last traded at $17.10, down 3.77% on the session. The quote above updates while this page is open; the figures below are drawn from NovoCure Limited Ordinary Shares’s own filings and are restated only when a new one is published.
NovoCure Limited Ordinary Shares trades on NASDAQ under the ticker NVCR. Its market capitalisation is $1.99 billion.
Valuation measures for NovoCure Limited Ordinary Shares, derived from the latest quote and its most recent SEC filing.
| Market cap | $1.99B |
|---|---|
| Enterprise value | $2.35B |
| Price / sales | 2.85 |
| Price / book | 5.89 |
| Beta | 1.58 |
Trailing-twelve-month figures tagged in NovoCure Limited Ordinary Shares's XBRL filings with the SEC.
| Revenue (TTM) | $699.19M |
|---|---|
| Net income (TTM) | -$148.56M |
| EPS (TTM) | -$1.30 |
| Gross margin | 76.13% |
| Operating margin | -22.08% |
| Return on equity | -43.94% |
| Cash | $93.70M |
Range and volume for NVCR over the past 52 weeks.
| 52-week high | $21.45 |
|---|---|
| 52-week low | $9.82 |
| Volume | 939.4K |
| Average volume | 1.68M |
| Previous close | $17.77 |
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.